For example, Duxbury et al. [15] reported that the overexpression of ILK in pancreatic cancer cells could enhance cell resistance to gemcitabine, while ILK knockdown could increase caspase-3-mediated apoptosis and increase cell sensitivity to gemcitabine. This evidence concerns the gene ILK and pancreatic neoplasm.